• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼洛替尼治疗期间的乙型肝炎病毒再激活

Hepatitis B Virus Reactivation under Treatment with Nilotinib.

作者信息

Temel Tuncer, Gunduz Eren, Sadigova Esmira, Uskudar Teke Hava, Meric Ozgenel Safak, Harmanci Ozakyol Aysegul

机构信息

Department of Gastroenterology, Eskisehir Osmangazi University, Eskisehir, Turkey.

Department of Hematology, Eskisehir Osmangazi University, Eskisehir, Turkey.

出版信息

Euroasian J Hepatogastroenterol. 2015 Jul-Dec;5(2):112-114. doi: 10.5005/jp-journals-10018-1147. Epub 2016 Jul 9.

DOI:10.5005/jp-journals-10018-1147
PMID:29201705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5578539/
Abstract

UNLABELLED

Hepatitis B virus (HBV) reactivation with imatinib, a tyrosine kinase inhibitor, has been reported in chronic myeloid leukemia. Nilotinib is a more potent second generation tyrosine kinase inhibitor and it inhibits the Src-family kinase LCK and hamper proliferation and function of CD8 (+) T lymphocytes. CD8 (+) T lymphocytes are the main cellular subset responsible for viral clearance in patients with HBV infection. We report a case of HBV reactivation under treatment with nilotinib. Fatal HBV reactivation is not usually related to death in chronic myeloid leukemia patients who have an expectation of longevity with well-tolerated oral drugs. Thus, screening for latent chronic HBV infections including assessment of hepatitis B surface antigen (HBsAg), antibody to hepatitis B core antigen (anti-HBc antibody) and antibody to hepatitis B surface antigen (anti-HBs), especially at countries with intermediate and high prevalence of HBsAg is warranted. Treatment with nucleoside analogs and close monitoring may be life-saving in this context.

HOW TO CITE THIS ARTICLE

Temel T, Gunduz E, Sadigova E, Teke HU, Ozgenel SM, Ozakyol AH. Hepatitis B Virus Reactivation under Treatment with Nilotinib. Euroasian J Hepato-Gastroenterol 2015;5(2):112-114.

摘要

未标注

在慢性髓性白血病中,已有使用酪氨酸激酶抑制剂伊马替尼导致乙型肝炎病毒(HBV)再激活的报道。尼罗替尼是一种更强效的第二代酪氨酸激酶抑制剂,它可抑制Src家族激酶LCK,并阻碍CD8(+) T淋巴细胞的增殖和功能。CD8(+) T淋巴细胞是HBV感染患者中负责病毒清除的主要细胞亚群。我们报告了1例接受尼罗替尼治疗期间发生HBV再激活的病例。致命性HBV再激活通常与慢性髓性白血病患者的死亡无关,这些患者预期可通过耐受性良好的口服药物长期存活。因此,有必要筛查潜在的慢性HBV感染,包括评估乙型肝炎表面抗原(HBsAg)、乙型肝炎核心抗体(抗-HBc抗体)和乙型肝炎表面抗体(抗-HBs),尤其是在HBsAg中等和高流行率的国家。在这种情况下,使用核苷类似物治疗并密切监测可能挽救生命。

如何引用本文

Temel T, Gunduz E, Sadigova E, Teke HU, Ozgenel SM, Ozakyol AH. 尼罗替尼治疗期间的乙型肝炎病毒再激活。《欧亚肝脏胃肠病学杂志》2015年;5(2):112 - 114。

相似文献

1
Hepatitis B Virus Reactivation under Treatment with Nilotinib.尼洛替尼治疗期间的乙型肝炎病毒再激活
Euroasian J Hepatogastroenterol. 2015 Jul-Dec;5(2):112-114. doi: 10.5005/jp-journals-10018-1147. Epub 2016 Jul 9.
2
Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor.慢性髓性白血病患者接受酪氨酸激酶抑制剂治疗后乙型肝炎病毒再激活。
World J Gastroenterol. 2013 Feb 28;19(8):1318-21. doi: 10.3748/wjg.v19.i8.1318.
3
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression.乙型肝炎表面抗原的遗传元件对于免疫逃逸至关重要,与免疫抑制后乙型肝炎病毒的再激活相关。
Hepatology. 2015 Mar;61(3):823-33. doi: 10.1002/hep.27604. Epub 2015 Jan 28.
4
Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.既往乙肝已缓解的淋巴瘤患者在接受含或不含利妥昔单抗的抗癌治疗过程中发生的乙肝病毒再激活。
J Clin Oncol. 2009 Feb 1;27(4):605-11. doi: 10.1200/JCO.2008.18.0182. Epub 2008 Dec 15.
5
Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: significance of hepatitis B core antibodies screening.乙肝表面抗原阴性的弥漫性大B细胞淋巴瘤患者中隐匿性乙型肝炎病毒的流行情况及化疗诱导的再激活:乙肝核心抗体筛查的意义
J Egypt Natl Canc Inst. 2015 Mar;27(1):11-8. doi: 10.1016/j.jnci.2015.01.004. Epub 2015 Feb 21.
6
Risk factors and outcomes of hepatitis B virus reactivation in hepatitis B surface antigen negative patients with hematological malignancies.乙肝表面抗原阴性血液系统恶性肿瘤患者乙肝病毒再激活的危险因素及结局
Hepatol Res. 2016 Jun;46(7):657-68. doi: 10.1111/hepr.12603. Epub 2015 Nov 5.
7
Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country.造血干细胞移植患者乙型肝炎病毒再激活:来自一个中部流行地区的单中心 20 年经验
Ann Hematol. 2020 Nov;99(11):2671-2677. doi: 10.1007/s00277-020-04206-z. Epub 2020 Jul 31.
8
Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatment.日本造血干细胞移植受者中乙型肝炎病毒再激活:核苷(酸)类似物预防和治疗的疗效
Int J Mol Sci. 2014 Nov 21;15(11):21455-67. doi: 10.3390/ijms151121455.
9
Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy.接受抗癌治疗的血液系统恶性肿瘤患者中乙型肝炎病毒再激活的预防与管理
World J Gastroenterol. 2016 Jul 28;22(28):6484-500. doi: 10.3748/wjg.v22.i28.6484.
10
Screening for and management of hepatitis B virus reactivation in patients treated with anti-B-cell therapy.接受抗B细胞治疗患者的乙型肝炎病毒再激活的筛查与管理
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):576-83. doi: 10.1182/asheducation-2014.1.576. Epub 2014 Nov 18.

引用本文的文献

1
HBV Reactivation in Immunosuppressed Patients: Screening, Prevention, and Management Including Solid Organ Transplant Recipients.免疫抑制患者中的乙肝病毒再激活:筛查、预防及管理,包括实体器官移植受者
Viruses. 2025 Mar 9;17(3):388. doi: 10.3390/v17030388.
2
High rate of hepatitis B reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in Korea.韩国慢性髓性白血病患者在酪氨酸激酶抑制剂治疗期间乙肝再激活率较高。
Blood Res. 2022 Dec 31;57(4):290-293. doi: 10.5045/br.2022.2022099. Epub 2022 Nov 24.
3
Association of Bcr-Abl Tyrosine Kinase Inhibitors With Hepatitis B Virus Reactivation Requiring Antiviral Treatment in Taiwan.台湾地区 Bcr-Abl 酪氨酸激酶抑制剂与乙型肝炎病毒再激活需要抗病毒治疗的相关性研究。
JAMA Netw Open. 2021 Apr 1;4(4):e214132. doi: 10.1001/jamanetworkopen.2021.4132.
4
Evaluation of Hepatitis B Reactivation Among Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors.评价酪氨酸激酶抑制剂治疗慢性髓性白血病患者的乙型肝炎病毒再激活情况。
Cancer Control. 2020 Jan-Dec;27(1):1073274820976594. doi: 10.1177/1073274820976594.

本文引用的文献

1
American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.美国胃肠病学会关于免疫抑制药物治疗期间预防和治疗乙型肝炎病毒再激活的指南。
Gastroenterology. 2015 Jan;148(1):215-9; quiz e16-7. doi: 10.1053/j.gastro.2014.10.039. Epub 2014 Oct 31.
2
Burden of pediatric hepatitis C.儿童丙型肝炎负担。
World J Gastroenterol. 2013 Nov 28;19(44):7880-8. doi: 10.3748/wjg.v19.i44.7880.
3
Immunosuppression and HBV reactivation.免疫抑制和 HBV 再激活。
Semin Liver Dis. 2013 May;33(2):167-77. doi: 10.1055/s-0033-1345722. Epub 2013 Jun 8.
4
The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C.乌司奴单抗治疗银屑病合并乙型或丙型肝炎患者的安全性特征。
Br J Dermatol. 2013 Dec;169(6):1295-303. doi: 10.1111/bjd.12461.
5
Hepatitis B "360".乙肝“360”
Transplant Proc. 2013 Apr;45(3):982-5. doi: 10.1016/j.transproceed.2013.02.099.
6
Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor.慢性髓性白血病患者接受酪氨酸激酶抑制剂治疗后乙型肝炎病毒再激活。
World J Gastroenterol. 2013 Feb 28;19(8):1318-21. doi: 10.3748/wjg.v19.i8.1318.
7
[Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy in patients with chronic myeloid leukemia: two cases report and literatures review].[慢性髓性白血病患者甲磺酸伊马替尼治疗相关的慢性乙型肝炎感染再激活:两例报告及文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2012 Sep;33(9):743-6. doi: 10.3760/cma.j.issn.0253-2727.2012.09.012.
8
Hepatitis B virus reactivation in a chronic myeloid leukemia patient treated with imatinib mesylate.甲磺酸伊马替尼治疗的慢性髓性白血病患者乙型肝炎病毒再激活。
Chin Med J (Engl). 2012 Jul;125(14):2636-7.
9
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.欧洲肝脏研究学会临床实践指南:慢性乙型肝炎病毒感染的管理
J Hepatol. 2012 Jul;57(1):167-85. doi: 10.1016/j.jhep.2012.02.010. Epub 2012 Mar 20.
10
Living donor liver transplantation for acute hepatic failure caused by reactivation of hepatitis B virus infection after chemotherapy for hematologic malignancy: case reports.血液系统恶性肿瘤化疗后乙肝病毒感染再激活所致急性肝衰竭的活体肝移植:病例报告
Transplant Proc. 2010 Apr;42(3):843-5. doi: 10.1016/j.transproceed.2010.02.038.